Bibliographic Details
| Title: |
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis. Reply. |
| Authors: |
Gillmore JD; University College London, London, United Kingdom j.gillmore@ucl.ac.uk., Maitland ML; Intellia Therapeutics, Cambridge, MA., Lebwohl D; Intellia Therapeutics, Cambridge, MA. |
| Source: |
The New England journal of medicine [N Engl J Med] 2021 Oct 28; Vol. 385 (18), pp. 1722-1723. |
| Publication Type: |
Letter; Comment |
| Journal Info: |
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
